市場調査レポート

商品コード

1084692

ヘパリン市場：規模、シェア、見通し、機会分析（2022年～2028年）

Heparin Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日: 2022年05月30日 | 発行: Coherent Market Insights

| ページ情報: 英文 149 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 705,420円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,097,320円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,567,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

冠動脈疾患、肺塞栓症、深部静脈血栓症などの疾患の増加が、ヘパリンの需要増加の主な要因の一つとなっています。

当レポートでは、世界のヘパリン市場について調査し、市場の概要とともに、製品タイプ別、剤形別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

ヒートマップ分析
企業プロファイル
- Anselm Pharmaceuticals
- Baxter International Inc.
- B. Braun Melsungen AG
- Bristol-Myers Squibb Co.
- Dr. Reddy's Laboratories Ltd.
- Fresenius SE &Co. KGaA
- Leap Labchem Co.
- LEO Pharma A/S
- Pfizer, Inc.
- Sanofi SA
- Syntex SA
- Teva Pharmaceutical Industries Ltd.
- United Biotech(P)Ltd.
アナリストの見解

第8章セクション

Product Code: CMI2602

Heparin is an anticoagulant used to decrease the clotting ability of blood and help to prevent harmful clots from forming in blood vessels. It is sometimes referred as a blood thinner, although it does not actually thin the blood. Heparin does not dissolve already formed blood clots, but it can prevent the clots from becoming larger and causing more serious problems. Pharmaceutical-grade heparin is derived from animal tissue. Heparin is commonly used in the treatment of coronary heart disease, pulmonary embolism, deep vein thrombosis, and atrial fibrillation, and in the prevention of thrombosis during extracorporeal membrane oxygenation and cardiopulmonary bypass.

Market Dynamics

Rising cases of conditions such as coronary heart disease, pulmonary embolism, and deep vein thrombosis is one of the major factors for increased demand of heparin drugs in the market. Myocardial infarction (MI) is one of the major complications of coronary heart disease. According to the American Heart Association 2018 report, coronary heart disease is the leading cause (43.8%) of deaths due to cardiovascular disease in the U.S., followed by stroke (16.8%). As per the Centres for Disease Control and Prevention (CDC) 2015 report, deep vein thrombosis affects nearly 900,000 individuals in the U.S. each year.

Despite major applications in chronic conditions, heparin is poorly absorbed by the intestine, therefore it must be given intravenously or subcutaneously. Moreover, the drug creates a significant risk of excessive bleeding due to anticlotting effect. Heparin also induce conditions such as thrombocytopenia (reduced number of circulating platelets) and hypersensitivity reactions. These factors can hamper the heparin market, during the forecast period.

Key features of the study:

This report provides in-depth analysis of the heparin market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global heparin market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Anselm Pharmaceuticals, Baxter International Inc., B. Braun Melsungen AG, Bristol-Myers Squibb Co., Dr. Reddy's Laboratories Ltd., Fresenius SE & Co. KGaA, Leap Labchem Co., LEO Pharma A/S, Pfizer, Inc., Sanofi S.A., Syntex S.A., Teva Pharmaceutical Industries Ltd., and United Biotech (P) Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global heparin market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for heparin market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Heparin Market, By Product Type:
- Unfractionated Heparin (UH)
- Low Molecular Weight Heparin (LMWH)
- Ultra-low Molecular Weight Heparin (ULMW)
Global Heparin Market, By Dosage Form:
- Injection
- Solutions
Global Heparin Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
  - By Product Type:
- Unfractionated Heparin (UH)
- Low Molecular Weight Heparin (LMWH)
- Ultra-low Molecular Weight Heparin (ULMW)
  - By Dosage Form:
- Injection
- Solutions
- Europe
  - By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
  - By Product Type:
- Unfractionated Heparin (UH)
- Low Molecular Weight Heparin (LMWH)
- Ultra-low Molecular Weight Heparin (ULMW)
  - By Dosage Form:
- Injection
- Solutions
- Asia Pacific
  - By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
  - By Product Type:
- Unfractionated Heparin (UH)
- Low Molecular Weight Heparin (LMWH)
- Ultra-low Molecular Weight Heparin (ULMW)
  - By Dosage Form:
- Injection
- Solutions
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
  - By Product Type:
- Unfractionated Heparin (UH)
- Low Molecular Weight Heparin (LMWH)
- Ultra-low Molecular Weight Heparin (ULMW)
  - By Dosage Form:
- Injection
- Solutions
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
  - By Product Type:
- Unfractionated Heparin (UH)
- Low Molecular Weight Heparin (LMWH)
- Ultra-low Molecular Weight Heparin (ULMW)
  - By Dosage Form:
- Injection
- Solutions
- Africa
  - By Country:
- South Africa
- Central Africa
- North Africa
  - By Product Type:
- Unfractionated Heparin (UH)
- Low Molecular Weight Heparin (LMWH)
- Ultra-low Molecular Weight Heparin (ULMW)
  - By Dosage Form:
- Injection
- Solutions
Company Profiles
- Anselm Pharmaceuticals*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Baxter International Inc.
- B. Braun Melsungen AG
- Bristol-Myers Squibb Co.
- Dr. Reddy's Laboratories Ltd.
- Fresenius SE & Co. KGaA
- Leap Labchem Co.
- LEO Pharma A/S
- Pfizer, Inc.
- Sanofi S.A.
- Syntex S.A.
- Teva Pharmaceutical Industries Ltd.
- United Biotech (P) Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Dosage Form
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Overview
Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Pipeline Analysis
Supply Chain Analysis
Regulatory Landscape
Epidemiology Analysis

4. Global Heparin Market, By Product Type, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Unfractionated Heparin (UH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Low Molecular Weight Heparin (LMWH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Ultra-low Molecular Weight Heparin (ULMW)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Heparin Market, By Dosage Form, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Heparin Market, By Region, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
North America
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Dosage Form, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
Europe
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Dosage Form, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Dosage Form, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Dosage Form, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Africa
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Dosage Form, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Northern Africa
- Central Africa
- South Africa
Middle East
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Dosage Form, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East

7. Competitive Landscape

Heat Map Analysis
Company Profiles
- Anselm Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Baxter International Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- B. Braun Melsungen AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bristol-Myers Squibb Co.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Dr. Reddy's Laboratories Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Fresenius SE & Co. KGaA
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Leap Labchem Co.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- LEO Pharma A/S
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Syntex S.A.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- United Biotech (P) Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
Analyst Views

8. Section

References
Research Methodology
About Us and Sales Contact

ヘパリン市場：規模、シェア、見通し、機会分析（2022年～2028年）

Heparin Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章調査目的・前提条件

第2章市場概要

第3章市場力学、規制、および動向分析

第4章世界のヘパリン市場：製品タイプ別、2017年～2028年、（100万米ドル）

第5章世界のヘパリン市場：剤形別、2017年～2028年、（100万米ドル）

第6章世界のヘパリン市場：地域別、2017年～2028年、（100万米ドル）

第7章競合情勢

第8章セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objective and Assumption

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Heparin Market, By Product Type, 2017 - 2028, (US$ Million)

5. Global Heparin Market, By Dosage Form, 2017 - 2028, (US$ Million)

6. Global Heparin Market, By Region, 2017 - 2028, (US$ Million)

7. Competitive Landscape

8. Section

ヘパリン市場：規模、シェア、見通し、機会分析（2022年～2028年）

Heparin Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章 調査目的・前提条件

第2章 市場概要

第3章 市場力学、規制、および動向分析

第4章 世界のヘパリン市場：製品タイプ別、2017年～2028年、（100万米ドル）

第5章 世界のヘパリン市場：剤形別、2017年～2028年、（100万米ドル）

第6章 世界のヘパリン市場：地域別、2017年～2028年、（100万米ドル）

第7章 競合情勢

第8章 セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objective and Assumption

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Heparin Market, By Product Type, 2017 - 2028, (US$ Million)

5. Global Heparin Market, By Dosage Form, 2017 - 2028, (US$ Million)

6. Global Heparin Market, By Region, 2017 - 2028, (US$ Million)

7. Competitive Landscape

8. Section

第1章調査目的・前提条件

第2章市場概要

第3章市場力学、規制、および動向分析

第4章世界のヘパリン市場：製品タイプ別、2017年～2028年、（100万米ドル）

第5章世界のヘパリン市場：剤形別、2017年～2028年、（100万米ドル）

第6章世界のヘパリン市場：地域別、2017年～2028年、（100万米ドル）

第7章競合情勢

第8章セクション